In the survival groups, ARCN1 showed a significant difference in gene expression patterns between variant carriers in the 0-2 year and 5-10 year survival groups, suggesting that ARCN1 may have a tumor suppressor effect as elevated expression thereof indicated longer survival times. Here, ARCN1 is linked to neoplasm.